Neuromyelitis Optica
What's New
Last Posted: Apr 15, 2024
- Association between FOXP3 polymorphisms and expression and neuromyelitis optica spectrum disorder risk in the Northern Chinese Han population.
Jing Liu, et al. Translational neuroscience 2024 0 (1) 20220337 - FCGR3A-V158F gene polymorphism: A potential predictor for rituximab dosing optimization in Chinese patients with neuromyelitis optica spectrum disorder.
Lei Cui, et al. Multiple sclerosis and related disorders 2024 0 105600 - Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Ho Jin Kim, et al. Annals of clinical and translational neurology 2023 0 - COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study.
Dongren Sun, et al. Frontiers in immunology 2023 0 1207514 - Causal Relations between Prodromal Infection and Neuromyelitis Optica Spectrum Disorder: A Mendelian Randomization Study.
Liang Wang, et al. European journal of neurology 2023 0 - Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study.
Nicolò Bruschi, et al. Neurology and therapy 2023 0 - Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China.
Gong Xiaoqing, et al. The International journal of neuroscience 2017 0 (6) 549-553 - Epidemiology of neuromyelitis optica in Latin America.
Alvarenga M P, et al. Multiple sclerosis journal - experimental, translational and clinical 2017 0 (3) 2055217317730098 - The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro.
Alvarenga M P, et al. Journal of neuroimmunology 2017 0 1-7 - A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis.
Zhao Xiujuan, et al. BMC ophthalmology 2018 0 (1) 247 - Mutation of the cellular adhesion molecule NECL2 is associated with neuromyelitis optica spectrum disorder.
Xu Yan, et al. Journal of the neurological sciences 2018 0 133-138 - [Expression of HLA-DP in patients with neuromyelitis optica spectrum disorders].
Chang Y Y, et al. Zhonghua yi xue za zhi 2019 0 (45) 3574-3580 - Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A.
Mealy Maureen A, et al. Neurology. Genetics 2018 0 (1) e213 - HLA-G Ins/Del polymorphism and +3142C/G SNP are not related to neuromyelitis optica spectrum disorder (NMOSD) development, disability status or anti-aquaporin 4 presence in Brazilian patients.
Gomes Nathália Augusta, et al. Journal of neuroimmunology 2019 0 577112 - Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
Matsushita Takuya, et al. Annals of clinical and translational neurology 2020 0 (11) 2082-2093 - Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases.
Hofer Livia Sophie, et al. Frontiers in immunology 2020 0 1188 - IRAK1 polymorphisms are associated with susceptibility to neuromyelitis optica spectrum disorder.
Shi Ziyan, et al. Multiple sclerosis and related disorders 2020 0 101438 - Interaction of HLA Class II rs9272219 and TMPO rs17028450 (Arg690Cys) Variants Affects Neuromyelitis Optica Spectrum Disorder Susceptibility in an Admixed Mexican Population.
Rosas-Madrigal Sandra, et al. Frontiers in genetics 2021 0 647343 - Clinical and genetic analysis of familial neuromyelitis optica spectrum disorder in Chinese: associated with ubiquitin-specific peptidase USP18 gene variants.
Chang Yanyu, et al. Journal of neurology, neurosurgery, and psychiatry 2022 0 (12) 1269-1275 - ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Yuyang, et al. Journal of clinical pharmacy and therapeutics 2022 0 (9) 1379-1387
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: